Paricalcitol, a new agent for the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis (Q33631931)

28 July 2017

1 reference

title

Paricalcitol, a new agent for the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis (English)

1 reference

secondary hyperparathyroidism

28 July 2017

0 references

1 reference

1 reference

Goldenberg MM

1

1 reference

28 July 2017

publication date

1 March 1999

1 reference

28 July 2017

published in

Clinical Therapeutics

1 reference

28 July 2017

volume

21

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

432-441

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

28 July 2017

1 reference

7 January 2021

THE CURE OF INFANTILE RICKETS BY SUNLIGHT

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

Identification of 1,25-Dihydroxycholecalciferol, a New Kidney Hormone controlling Calcium Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

The spectrum of bone disease in end-stage renal failure--an evolving disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

Renal osteodystrophy: pathogenesis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

Actions of 1 alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on mineral metabolism in man. I. Effects on net absorption of phosphorus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

Intracellular Localization and Translocation of 1.ALPHA.,25-Dihydroxyvitamin D3 Receptor in Osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

Mechanism of vitamin D action and its regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

An equilibrium and kinetic study of 1,25-dihydroxyvitamin D3 binding to chicken intestinal cytosol employing high specific activity 1,25-dihydroxy[3H-26, 27]vitamin D3

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

Effect of hemodialysis on the pharmacokinetics of 19-nor-1alpha,25-dihydroxyvitamin D2

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

Therapy of secondary hyperparathyroidism with 19-nor-1alpha,25-dihydroxyvitamin D2

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988299-5

7 January 2021

10.1016/S0149-2918(00)88299-5

Identifiers

DOI

1 reference

28 July 2017

1 reference